Before beginning any new medication or treatment, it’s important to understand what it is, how it works, and what to watch for. The information below is intended to help you have an informed conversation with your healthcare provider about tirzepatide.

What Tirzepatide Is Used For

Tirzepatide is prescribed alongside lifestyle changes such as nutrition and physical activity to help adults with type 2 diabetes improve blood sugar management.

Who Should Not Use Tirzepatide

Tirzepatide is not appropriate for individuals with:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Certain severe digestive conditions, including gastroparesis or significant gastrointestinal motility disorders

Patients should discuss their full medical history with a licensed healthcare provider before beginning treatment.

Warnings and Safety Precautions

Possible Thyroid Tumor Risk

Medications within the GLP-1 receptor agonist class have been linked to thyroid C-cell tumors in some studies. Before starting tirzepatide, healthcare providers may review thyroid-related risk factors and medical history.

Patients should seek medical attention if symptoms such as neck swelling, persistent hoarseness, difficulty swallowing, or shortness of breath occur.

Pancreatitis Risk

Inflammation of the pancreas has been reported in patients using GLP-1-based medications, including tirzepatide.

Warning signs may include severe abdominal pain that does not go away and may spread toward the back, with or without vomiting. Patients experiencing these symptoms should stop using the medication and contact a healthcare provider immediately.

Low Blood Sugar Risk

Using tirzepatide together with insulin or medications that increase insulin production may raise the risk of hypoglycemia.

In some cases, medication adjustments may be recommended by a healthcare provider to help reduce this risk.

Kidney Function Concerns

Severe nausea, vomiting, diarrhea, or dehydration may contribute to worsening kidney function in certain individuals.

Healthcare providers may recommend monitoring kidney function during treatment when appropriate.

Serious Allergic Reactions

Although uncommon, severe allergic reactions have been reported, including swelling, rash, hives, and anaphylaxis.

Patients should discontinue use and seek immediate medical care if symptoms of a serious allergic reaction occur.

Digestive Side Effects

Some individuals may experience gastrointestinal symptoms during treatment, especially during dose increases or when first starting therapy.

Possible side effects may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Stomach discomfort or abdominal pain

These symptoms may improve over time for some patients.

Pregnancy and Breastfeeding

Patients who are pregnant, planning to become pregnant, or currently breastfeeding should discuss treatment risks and options with their healthcare provider before using tirzepatide.

It is not currently known whether tirzepatide passes into breast milk.

Medication Interactions

Tirzepatide may affect the absorption or effectiveness of certain medications, particularly those influenced by stomach emptying and gastrointestinal motility.

Additional caution may be needed when combining tirzepatide with medications associated with low blood sugar risk.

Patients should inform their healthcare provider about all medications, supplements, and over-the-counter products they are currently using.

Patient Guidance

Patients should carefully follow provider instructions regarding dosing, administration, nutrition, hydration, and physical activity while using tirzepatide.

Healthcare providers may also discuss:

  • Potential gastrointestinal side effects
  • Signs of low blood sugar
  • Symptoms associated with pancreatitis
  • Possible thyroid-related symptoms
  • Serious allergic reactions requiring immediate medical attention
Compounded Medication Information

This medication may be compounded by a properly licensed pharmacy pursuant to a patient-specific prescription issued by a licensed healthcare provider after an appropriate medical evaluation.

Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration for safety, effectiveness, or quality in the same manner as FDA-approved medications.

Compounded tirzepatide is not approved by the FDA for weight loss purposes.

Any discussion of potential benefits is based on emerging research, provider discretion, and individual patient circumstances. Results and experiences may vary between individuals.

This compounded formulation is not manufactured, sponsored, endorsed, or approved by Eli Lilly and is not intended to replace any FDA-approved tirzepatide product.

Product appearance and packaging may differ from images displayed on the website or marketing materials.

Disclaimer

Compounded medications are prepared specifically for an individual patient based on the judgment and prescription of a licensed medical provider.

These medications are not FDA-approved, and patients should speak directly with their healthcare provider regarding potential benefits, risks, side effects, and available treatment options.

Pricing Information

Many standard dosing levels are included within one program structure. Certain higher dosing levels or specialty treatment adjustments may involve additional costs depending on provider recommendations and patient needs.